Carbamic Acid

Carbamic Acid

SCHEMBL2476276

NC(=O)O.NC(=O)O.NC(=O)O.c1cnnnc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.44
P2RX7 Q99572 1/20 0.37
CYP1A2 P05177 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
SARM1 Q6SZW1 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT6 Q8N6T7 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36
SIRT5 Q9NXA8 1/20 0.36
SIRT4 Q9Y6E7 1/20 0.36
NAPRT Q6XQN6 2/20 0.34
TDP1 Q9NUW8 2/20 0.33
PARP1 P09874 2/20 0.33
CYP3A4 P08684 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
BLM P54132 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL2342697 1.00 ACHE (0.44) ACHEP2RX7CYP1A2F7F3
Urea SCHEMBL10874658 0.90 ALDH1A1 (0.40) P2RX7F7F3SARM1SIRT2
Bicarbonate SCHEMBL9005252 0.87 CA1 (0.36) P2RX7CYP1A2NAPRTL3MBTL1HCAR2
Urea SCHEMBL1618388 0.85 ALDH1A1 (0.35) P2RX7F7F3SARM1SIRT2
Urea SCHEMBL11744906 0.85 ALDH1A1 (0.35) P2RX7F7F3SARM1SIRT2
Acetamide SCHEMBL5605742 0.85 LMNA (0.47) P2RX7F7F3SARM1SIRT2
Carbamic Acid SCHEMBL4049806 0.84 ACHE (0.47) ACHEF7F3SARM1SIRT2
Bicarbonate SCHEMBL29455645 0.84 CA1 (0.33) NAPRT
Pyridazine SCHEMBL20893379 0.84 ACHE (0.47) ACHEP2RX7CYP1A2F7F3
Carbamic Acid SCHEMBL30541730 0.84 ACHE (0.47) ACHEF7F3SARM1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604922-B1 Durable compositions and use of same CYTEC TECH CORP (US) 2004-11-17 EP claimed
EP-0812867-B1 Process for lacquering substrates DU PONT (US) 2003-08-20 EP claimed
EP-0812867-A1 Process for lacquering substrates Herberts Gesellschaft mit beschränkter Haftung (DE) 1997-12-17 EP claimed
EP-0604922-A1 Durable compositions and use of same CYTEC TECHNOLOGY CORP. (US) 1994-07-06 EP claimed
EP-2373633-B1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE (AT) 2014-04-16 EP disclosed
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates BOREALIS AGROLINZ MELAMINE GMBH (AT) 2011-12-01 US disclosed
EP-2373633-A1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES Borealis Agrolinz Melamine GmbH (AT) 2011-10-12 EP disclosed
WO-2010066683-A1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE GMBH (AT) 2010-06-17 WO disclosed
EP-0604922-B1 Durable compositions and use of same CYTEC TECH CORP (US) 2004-11-17 EP disclosed
EP-0930303-B1 A process for preparing isocyanate compounds from haloaminotriazines and acid halides CYTEC TECH CORP (US) 2004-02-04 EP disclosed
EP-0812867-B1 Process for lacquering substrates DU PONT (US) 2003-08-20 EP disclosed
EP-0933371-B1 N-halo acid amides CYTEC TECH CORP (US) 2003-04-09 EP disclosed
US-5574103-A ETCH RESISTANCE, NO FORMALDEHYDE CYTEC TECHNOLOGY CORP. (US) 1996-11-12 US disclosed
US-5574103-A ETCH RESISTANCE, NO FORMALDEHYDE CYTEC TECHNOLOGY CORP. (US) 1996-11-12 US disclosed
US-5571915-A Process for preparing amide derivatives from haloaminotriazines and acid halides CYTEC TECHNOLOGY CORP. (US) 1996-11-05 US disclosed
US-5405959-A Haloaminotraizines and acid halides CYTEC TECHNOLOGY CORP. (US) 1995-04-11 US disclosed
EP-0604922-A1 Durable compositions and use of same CYTEC TECHNOLOGY CORP. (US) 1994-07-06 EP disclosed
US-5288865-A Process for preparing amide derivatives from haloaminotriazines and acid halides AMERICAN CYANAMID COMPANY (US) 1994-02-22 US disclosed
EP-0565774-A2 Process for preparing amide derivatives from halominotriazines and acid halides CYTEC TECHNOLOGY CORP. (US) 1993-10-20 EP disclosed
EP-0541966-A2 Process for preparing amide derivatives from halomines and acid halides AMERICAN CYANAMID COMPANY (US) 1993-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates CA3, CA7, KAT5 ACHE 101/4885P2RX7 3126/4885CYP1A2 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.